Serum hyaluronidase aberrations in metabolic and morphogenetic disorders

Glycoconjugate Journal

Volumn 22, Issue 7-9, 2005, Pages 395-400

  Fiszer Szafarz, Berta ^a   Czartoryska, Barbara ^a,b   Tylki Szymanska, Anna ^c  

^a INSTITUT CURIE   (France)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^c CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

Achondroplasia; Dysostosis multiplex; Human; Hypophosphotemic rickets; I cell disease; Leukocyte hyaluronidase; Sanfilippo A disease; Serum hyaluronan; Serum hyaluronidase

Indexed keywords

BETA GLUCURONIDASE; HYALURONIC ACID; HYALURONIDASE; LEUKOCYTE ENZYME; N ACETYL BETA GLUCOSAMINIDASE;

ACHONDROPLASIA; ADOLESCENT; ADULT; ARTICLE; BONE DEFECT; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DONOR; EHLERS DANLOS SYNDROME; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME DEFECT; FEMALE; GENETIC DISORDER; GM1 GANGLIOSIDOSIS; HEALTH SURVEY; HUMAN; HUMAN CELL; HYPOPHOSPHATEMIA; LIMB; MALE; MARFAN SYNDROME; METABOLIC DISORDER; MORPHOGENESIS; MORQUIO SYNDROME; MUCOLIPIDOSIS TYPE 2; MUCOPOLYSACCHARIDOSIS; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RICKETS; SANFILIPPO SYNDROME; SHORT STATURE; ZYMOGRAPHY;

ACETYLGLUCOSAMINIDASE; ACHONDROPLASIA; ADOLESCENT; BONE DISEASES, METABOLIC; CHILD; CHILD, PRESCHOOL; DYSOSTOSES; FEMALE; GLUCURONIDASE; HUMANS; HYALURONOGLUCOSAMINIDASE; HYPOPHOSPHATEMIA, FAMILIAL; MALE; MUCOLIPIDOSES; MUCOPOLYSACCHARIDOSES;

EID: 28344434468     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-005-1390-2     Document Type: Article

References (41)

1. Neufeld EF, Meunzer J, The Mucopolysaccharidoses. In The Metabolic and Molecular Basis of Inherited Diseases, edited by Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, (McGraw-Hill, New York, 2001), 8th, pp. 3421-52.
2. Csoka AB, Scherer SW, Stern R, Expression analysis of six paralogous human hyaluronidase genes clustered on chromosomes 3p21 and 7q31, Genomics 60, 356-61 (1999).
3. Fiszer-Szafarz B, Szafarz D, Vannier P, Polymorphism of hyaluronidase in serum from man, various mouse strains and other vertebrate species revealed by electrophoresis, Biol Cell 68, 95-100 (1990).
4. Fiszer-Szafarz B, Vannier P, Litynska A, Zou L, Czartoryska B, Tilki Szymanska A, Hyaluronidase in human somatic tissues and urine: polymorphism and the activity in diseases, Acta Bioch Pol 42, 31-4 (1995).
5. Fiszer-Szafarz B, Litynska A, Zou L, Human hyaluronidases: electrophoretic multiple forms in somatic tissues and body fluids. Evidence for conserved hyaluronidase potential N-glycosylation sites in different mammalian species, J Biochem Biophys Methods 45, 103-16 (2000).
6. Fiszer-Szafarz B, Litynska A, Zou L, Human hyaluronidase polymorphism and evidence for conserved hyaluronidase glycosylation sites in mammalian and non-mammalian species. In Hyaluronan. Chemical, biochemical and biological aspects, edited by Kennedy JF, Phillips GO, Williams PA, Hascall VC, (Woodhead Publishing Ltd, Cambridge, UK, 2002) 1, pp. 253-58.
7. Girard N, Maingonnat C, Bertrand P, Tilly H, Vannier JP, Delpech B, Human monocytes synthesize hyaluronidase, Brit J Haematol 119, 199-203 (2002).
8. Lepperdinger G, Strobl B, Kreil G, HYAL2, a human gene expressed in many cells, encodes a lysosomal hyaluronidase with a novel type of specificity. J Biol Chem 273, 22466-70 (1998).
9. Stern R, Devising a pathway for hyaluronan catabolism. Are we there yet? Glycobiology, 13, 1-11 (2003).
10. Stephens RW, Sutherland J, Ghosh P, Tailor TKF, Human serum and synovial fluid hyaluronidase. Bovine testicular hyaluronidase is not a valid structure in drug evaluation studies, Biochem Pharmacol 25, 1507-11 (1976).
11. Berlepsch KV, Uber hyaluronidase und antihyaluronidase des menschlichen serums, Biochem Z 329, 542-8 (1958).
12. Fiszer-Szafarz B, Demonstration of a new hyaluronidase inhibitor in serum of cancer patients, Proc Soc Exp Biol 129, 300-02 (1968).
13. Glick D, Hyaluronidase inhibitor of human blood serum in health and disease, J Mt Sinai Hosp NY 17, 207-28 (1950).
14. Kulonen E, On hyaluronidase inhibitors in human blood, Acta Med Scand 136, 401-07 (1950)
15. Mio K, Stern R, Inhibitors of the hyaluronidases, Matrix Biol 21, 31-7 (2002).
16. Kulyk WM, Kosher RA, Temporal and spatial analysis of hyaluronidase activity during development of the embryonic chick limb bud. Devop Biol 120, 535-41(1987).
17. Nathanson MA, Hyaluronates in developing skeletal tissues, Clin Orthop 251, 275-89 (1990).
18. Roden L, Campbell P, Fraser JR, Laurent TC, Pertoft H, Thompson JN, Enzymic pathways of hyaluronan catabolism. In The Biology of Hyaluronan, Ciba Foundation Symposium 143, edited by Evered D, Whelan J, (J Wiley & Sons, Chichester UK, 1989), pp. 60-86.
19. Liu DC, Pearlman E, Diaconu E, Guo K, Mori H, Haqqi T, Markowitz S, Willson J, Sy MS, Expression of hyaluronidase by tumor cells induces angiogenesis in vivo, Proc Natl Acad Sci USA, 93, 7832-37(1996).
20. Fiszer-Szafarz B, Effect of human cancerous serum on the chick embryo, Cancer Res 27, 191-7 (1967).
21. Nagaya H, Ymagata T, Ymagata S, Iyoda K, Ito H, Hasegawa Y, Iwata H. Examination of synovial fluid and serum hyaluronidase activity as a joint marker in rheumatoid arthritis and osteoarthritis patients (by zymography), Ann Rheum Dis 58, 186-88 (1999).
22. Delpech B, Girard N, Bertrand P, Courel MN, Chauzy C, Delpech A, Hyaluronan: fundamental principles and applications in cancer, J Internal Med 242, 41-8 (1997).
23. Duran-Reynals F, Stewart FW, The action of tumor extracts on the spread of experimental vaccinia of the rabbit, Amer J Cancer 15, 2790-7 (1931).
24. Fiszer-Szafarz B, Gullino PM, Hyaluronidase activity of normal and neoplastic interstitial fluid, Proc Soc Exp Biol Med 133, 805-7 (1970).
25. Lundin A, Engström-Laurent A, Hällgren R, Michaëlsson G, Circulating hyaluronate in psoriasis, Brit J Dermatol 112, 663-71 (1985).
26. Longas MO, Wisch P, Lebwohl MG, Fleischmajer R, Glycosaminoglycans of skin and urine in pseudoxanthoma elasticum: evidence for chondroitin 6-sulfate alteration, Clin Chim Acta 155, 227-36 (1986).
27. Neudecker BA, Stern R, Connolly MK, Aberrant serum hyaluronan and hyaluronidase levels in scleroderma, Brit J Dermatol 1, 469-76 (2004).
28. Natowicz MR, Short MP, Wang Y, Dickersin GR, Gebhardt MC, Rosenthal DI, Sims KB, Rosenberg AE, Clinical and biochemical manifestations of hyaluronidase deficiency, N Engl J Med 335, 1029-33 (1996).
29. Triggs-Raine B, Salo TJ, Zhang H, Wicklow BA, Natowicz MR, Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX, Proc Natl Acad Sci USA 96, 6296-300 (1999).
30. Kampine JP, Brady RO, Kanfer JN, Diagnosis of Gaucher disease and Nieman-Pick disease with small samples of venous blood, Science 155, 86-8 (1967).
31. Fiszer-Szafarz B, Hyaluronidase polymorphism detected by polyacrylamide gel electrophoresis. Application to hyaluronidases from bacteria, slime molds, bee and snake venoms, bovine testes, rat liver lysosomes, and human serum, Anal Biochem 143, 76-81 (1984).
32. Green MR, Pastewka JV, Identification of sialic acid-rich glycoproteins on polyacrylamide gels, Anal Biochem 65, 66-72 (1975).
33. Glaser JH, Sly WS, β-Glucuronidase deficiency mucopoysaccharidosis: method for enzymatic diagnosis, J Lab Clin Med 82, 969-77 (1973).
34. Hindman J, Cotlier E, Glycosidases in normal human leukocytes and abnormalities in GM1-gangliosidosis, Clin Chem 18, 971-8 (1972).
35. Delpech B, Bertrand P, Maingonnat C, Immunoenzyme assay of the hyaluronic acid-hyaluronectin interaction : application to the detection of hyaluronic acid in serum of normal subjects and cancer patients, Anal Biochem 149, 555-65 (1985).
36. Pennock CA, A review and selection of simple laboratory methods used for the study of glycosaminoglycan excretion and diagnosis of mucopolysaccharidoses, J Clin Path 29, 111-23 (1976).
37. Natowicz MR, Wang Y, Plasma hyaluronidase activity in mucolipidosis II and III: marked differences from other lysosomal enzymes, Am J Med Genet, 65, 209-12 (1996).
38. Creek KE, Sly WS, The role of the phosphomannosyl receptor in the transport of acid hydrolases to lysosomes. In Lysosomes in Biology and Pathology, edited by Dingle JT, Dean RT, Sly WS, (Elsevier Science Publishers, BV, Amsterdam, 1984), pp 63-82.
39. Bignami A, Hosley M, Dahl D, Hyaluronic acid and hyaluronic acid-binding proteins in brain extracellular matrix, Anat Embryol 188, 419-33 (1993).
40. Ripellino JA, Margolis RU, Margolis RK, Immunoelectron microscopic localization of hyaluronic acid-binding region and link protein epitopes in brain, J Cell Biol 108, 1899-907 (1989).
41. Kint JA, Secondarily induced lysosomal abnormalities in mucopolysaccharidoses, In The Developing Brain and its Disorders, edited by Arima M, Suzuki Y, Yabuuchi H (Univ. of Tokyo Press, Tokyo 1984), pp. 139-50.